Regulatory, Patent Reform Needed for Inhalers for Asthma, COPD
FRIDAY, May 20, 2022 -- Of the 62 inhalers approved by the U.S. Food and Drug Administration since 1986, few have offered novel drug innovations, according to a study published online May 17 in Health Affairs.
Noting that inhalers face limited...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Asthma | Chronic Obstructive Pulmonary | Food and Drug Administration (FDA) | Pharmaceuticals | Study